B
Beyond Verbal
Health Tech & Medtech · Tel Aviv-Yafo, Israel · Founded 2012
Beyond Verbal is committed to identifying proprietary Vocal Biomarkers for personalized healthcare screening & monitoring based on voice MoreLess
Beyond Verbal operates in the health technology sector, specializing in voice analysis to monitor and detect health conditions. The company serves healthcare providers, researchers, and technology integrators by offering a software solution that runs on all voice platforms. Beyond Verbal's core product leverages proprietary AI and big data analytics to identify vocal biomarkers, which are unique voice patterns that can indicate health status. The business model revolves around licensing its Vocalis API to clients, enabling them to integrate voice analysis capabilities into their own systems. Revenue is generated through subscription fees and data analytics services. The company aims to be an early adopter in the commercialization of vocal biomarkers, providing actionable insights to care teams for better health monitoring and risk assessment.
Keywords: vocal biomarkers, AI analytics, voice analysis, health monitoring, big data, Vocalis API, healthcare technology, proprietary voice technology, actionable insights, early adopter.
Talent graph
Beyond Verbal's talent
Source: Dealroom Talent Intelligence.
Investors
5 investors on Beyond Verbal's cap table
Sourced from Dealroom's funding and investor records.



Global footprint
Where Beyond Verbal has talent and traffic
Market sentiment
What the market is saying about Beyond Verbal
An AI-synthesized read of the highest-engagement posts about Beyond Verbal on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beyond Verbal on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.